"Evaluation of acute myeloid leukemia induction regimens in elderly patients with unfavorable risk cytogenetics that are candidates for intensive remission therapy" by Monica Tadros

Presentation

Evaluation of acute myeloid leukemia induction regimens in elderly patients with unfavorable risk cytogenetics that are candidates for intensive remission therapy

All Publications

Monica Tadros, Miami Cancer Institute
Guenther Koehne, Miami Cancer Institute
Talia Zahra, Miami Cancer Institute
Moe Shwin, Miami Cancer Institute
Jessica Unzaga, Miami Cancer Institute
Nicholas Chow, Miami Cancer Institute

Download

Publication Date

3-1-2020

Presented At:

Hematology/Oncology Pharmacy Association Annual Conference

Content Type

application/pdf

Resident/Fellow

Monica Tadros - Pharmacy Resident PGY2

Author Credentials

Monica Tadros, Pharm.D., BCPS

Guenther Koehne, M.D., Ph.D.

Talia Zahra, M.D.

Moe Shwin, Pharm.D., BCOP

Nicolas Chow, Pharm.D., BCOP

Jessica Unzaga, Pharm.D., BCPS, BCOP

Disciplines

Citation Information

Monica Tadros, Guenther Koehne, Talia Zahra, Moe Shwin, et al.. "Evaluation of acute myeloid leukemia induction regimens in elderly patients with unfavorable risk cytogenetics that are candidates for intensive remission therapy" (2020)
Available at: http://works.bepress.com/talia-zahra/13/